Grace Aldrovandi
MD, CM
University of California, Los Angeles, United States
Related Materials
The 6th International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment took place on the 7th and 8th October 2020.
The understanding of the human microbiome continues to grow rapidly. However information on the role of the microbiome on HIV infection pathogenesis, prevention, and treatment is still limited. Whereas research in this area may be presented at major conferences, there are often limited sessions devoted to this topic as well as limited time for in-depth discussion and debate among cross-disciplinary experts on new data and their implications. The aim of this workshop is to provide increased opportunities for discussion and exchange of knowledge following formal presentation of the latest research.
The multidisciplinary nature and the significance in furthering our ability to develop novel prevention and therapeutic strategies for HIV will lead to the reduction of new HIV infections and the burden of non-communicable diseases in individuals living with HIV. We also will be able to learn how the host microbiome can influence responses to our current HIV therapies.
This 2-day workshop had invited lectures by key opinion leaders, oral abstract presentations, and poster presentations. Ample time was allocated for discussion in an intimate workshop setting. The workshop was unique in its approach, as it engaged basic scientists and clinicians from the HIV field and leading scientists involved in microbiome research including bioinformatics experts.
Clinicians and researchers with an interest in Microbiome in HIV Pathogenesis, Prevention and Treatment were invited to attend this workshop.
MD, CM
University of California, Los Angeles, United States
MD
University of Pennsylvania, Perelman School of Medicine, United States
PhD
Rush University Medical Center, United States
General Information
Practical Information